Top novel drug approvals: February 2019
Cablivi and Egaten were the two top novel drugs approved last month, with a focus on parasitic infestation and the rare disorder, aTTP...
List view / Grid view
Cablivi and Egaten were the two top novel drugs approved last month, with a focus on parasitic infestation and the rare disorder, aTTP...
The FDA has approved the first specific therapy for the rare blood clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP)...